文献速递白血病

YBX1通过m6A依赖性方式调控BCL2稳定性维持髓系白血病细胞存活

YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
PubMed 文献 · Blood · 2021-01-01

该研究探讨RNA结合蛋白YBX1在髓系白血病中的作用。研究发现YBX1在髓系白血病细胞中表达显著上调,敲除YBX1可诱导凋亡、促进分化并降低增殖和白血病能力,且对正常造血无明显影响。机制上YBX1与IGF2BPs互作稳定m6A标记RNA,其缺失以m6A依赖性方式促进MYC和BCL2 mRNA降解。

要点

  • YBX1在髓系白血病细胞中表达显著上调,是白血病细胞存活所必需。
  • 敲除YBX1诱导凋亡和分化,降低增殖和白血病能力,对正常造血无明显影响。
  • YBX1与IGF2BPs互作稳定m6A标记RNA,缺失导致MYC和BCL2 mRNA以m6A依赖性方式降解。

核心结论

  • YBX1以m6A依赖性方式选择性维持髓系白血病细胞存活,可能成为治疗靶点。

研究设计与样本

  • 研究使用原代人及小鼠急性髓系白血病细胞,进行体外和体内实验。

主要发现

  • YBX1在髓系白血病细胞中表达显著上调。
  • 敲除YBX1显著诱导凋亡、促进分化,并降低增殖和原代白血病细胞的白血病能力。
  • 敲除YBX1对正常造血无明显影响。
  • YBX1与IGF2BPs互作并稳定m6A标记RNA。
  • YBX1缺失以m6A依赖性方式失调凋亡相关基因表达并促进MYC和BCL2 mRNA降解。

临床怎么用

  • YBX1可能作为髓系白血病的治疗靶点,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RNA-binding proteins (RBPs) are critical regulators of transcription and translation that are often dysregulated in cancer. Although RBPs are increasingly recognized as being important for normal hematopoiesis and for hematologic malignancies as oncogenes or tumor suppressors, RBPs that are essential for the maintenance and survival of leukemia remain elusive. Here we show that YBX1 is specifically required for maintaining myeloid leukemia cell survival in an N6-methyladenosine (m6A)-dependent manner. We found that expression of YBX1 is significantly upregulated in myeloid leukemia cells, and deletion of YBX1 dramatically induces apoptosis and promotes differentiation coupled with reduced proliferation and impaired leukemic capacity of primary human and mouse acute myeloid leukemia cells in vitro and in vivo. Loss of YBX1 has no obvious effect on normal hematopoiesis. Mechanistically, YBX1 interacts with insulin-like growth factor 2 messenger RNA (mRNA)-binding proteins (IGF2BPs) and stabilizes m6A-tagged RNA. Moreover, YBX1 deficiency dysregulates the expression of apoptosis-related genes and promotes mRNA decay of MYC and BCL2 in an m6A-dependent manner, which contributes to the defective survival that results from deletion of YBX1. Thus, our findings have uncovered a selective and critical role of YBX1 in maintaining myeloid leukemia survival, which might provide a rationale for the therapeutic targeting of YBX1 in myeloid leukemia.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Feng M, Xie X, Han G, et al. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner. Blood. 2021. PMID: 33763698. doi:10.1182/blood.2020009676

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。